1. c-myc and bcl-2 Expression in supraglottic squamous cell carcinoma of the larynx.
- Author
-
Ozdek A, Sarac S, Akyol MU, Sungur A, and Yilmaz T
- Subjects
- Adult, Aged, Carcinoma, Squamous Cell pathology, Cohort Studies, Humans, Laryngeal Neoplasms pathology, Male, Middle Aged, Prognosis, Retrospective Studies, Survival Analysis, Carcinoma, Squamous Cell genetics, Genes, bcl-2 genetics, Genes, myc genetics, Laryngeal Neoplasms genetics
- Abstract
Objectives: To evaluate the expression and prognostic significance of c-myc and bcl-2 oncogenes in squamous cell carcinoma (SCC) of the supraglottic larynx. Study design A retrospective cohort study of 61 patients who underwent surgery for SCC of the supraglottic larynx. Gender, age, TNM status, operative procedure, recurrences, and disease-free survival periods were recorded., Methods: Hematoxylin and eosin-stained sections were reexamined for grade, invasion of tumor margins, lymphovascular invasion, lymphocyte infiltration, and perineural invasion. Immunohistochemical detection of c-myc and bcl-2 oncogenes was performed using monoclonal antibodies., Results: No correlation was observed between either c-myc or bcl-2 and the clinical and histopathologic parameters. Survival analysis revealed no correlation of either c-myc (P = 0.88) or bcl-2 (P = 0.85) with the disease-free survival. c-myc expression was found to be significantly higher in bcl-2-positive patients (P = 0.001)., Conclusion: Neither c-myc nor bcl-2 had shown to be prognostic factor for laryngeal carcinoma in this present study. Correlation between c-myc and bcl-2 supports the experimental observations of cooperative action between these two genes in tumorigenesis.
- Published
- 2004
- Full Text
- View/download PDF